| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/20/2008 | US20080069821 Avian pandemic; immunogens; antibodies; immunology |
| 03/20/2008 | US20080069813 Acid hydrolyzed IgG concentrate which prevents viral invasion |
| 03/20/2008 | US20080069800 System for High Production of Natural and Personalized Interferons |
| 03/20/2008 | US20080069797 Rapamycin and il-10 for the treatment of immune diseases |
| 03/20/2008 | US20080069780 Triethylene glycol, dipropylene glycol, propylene glycol; need to shake the container prior to use is eliminated; leave little or no visible residue on hard surfaces |
| 03/20/2008 | DE102006039912A1 Substituierte Spirotetronsäuren und ihre Verwendung Substituted Spirotetronsäuren and their use |
| 03/20/2008 | DE102006037786A1 Nukleoside, diese enthaltendes Arzneimittel und deren Verwendung Nucleosides containing these drugs and their use |
| 03/20/2008 | DE102006030479A1 Indazolderivate Indazole derivatives |
| 03/20/2008 | DE10080167B4 Medikament zur Hemmung der Expression eines vorgegebenen Gens Medicament for inhibiting the expression of a given gene |
| 03/20/2008 | CA2663279A1 Use of 2-6-(3-amino-piperidin-1-yl)-3-methyl-2,-4-dioxo-3,4-dihydro-2h-pyridimin-1-ylmethyl-4-fluoro-benzonitrile for treating diabetes, cancer,autoimmune disorders and hiv infection |
| 03/20/2008 | CA2663234A1 Novel phenylacetic acid derivative |
| 03/20/2008 | CA2663159A1 Organic compounds and their uses |
| 03/20/2008 | CA2642147A1 Influenza antibodies, compositions, and related methods |
| 03/19/2008 | EP1900818A2 Neisserial antigens |
| 03/19/2008 | EP1900815A2 In vivo production of small interfering RNAs that mediate gene silencing |
| 03/19/2008 | EP1900814A1 sc(Fv)2 SITE-DIRECTED MUTANT |
| 03/19/2008 | EP1900753A2 Method of administering therapeutic polypeptides, and polypeptides therefor |
| 03/19/2008 | EP1900732A1 Novel nitrogenated heterocyclic compound and salt thereof |
| 03/19/2008 | EP1900378A1 Pharmaceutical compositions for the treatment of fungal infections |
| 03/19/2008 | EP1900376A2 Synergistic inhibition of HIV-1 fusion and attachment, compsitions and antobodies thereto |
| 03/19/2008 | EP1900364A2 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 03/19/2008 | EP1900360A1 Homer a new target of treating psychiatric disorders |
| 03/19/2008 | EP1899352A1 1- [2' , 3' -dideoxy-3' c- (hydroxymethyl) - beta-d-erythro-pentofuranosyl] cytosine derivatives as hiv inhibitors |
| 03/19/2008 | EP1899331A1 Homomorpholine oxazolidinones as antibacterial agents |
| 03/19/2008 | EP1898952A2 Synergistic mixtures of aromatic alcohols and derivatives thereof and tropolone (derivatives) |
| 03/19/2008 | EP1898948A1 Polyinosinic acid-polycytidylic acid-based adjuvant |
| 03/19/2008 | EP1898935A2 North-2'-deoxy-methanocarbathymidines as antiviral agents against poxviruses |
| 03/19/2008 | EP1898925A2 Method for the treatment of acne |
| 03/19/2008 | EP1898914A1 Quinoline derivatives as antibacterial agents |
| 03/19/2008 | EP1898910A1 Quinoline derivatives as antibacterial agents |
| 03/19/2008 | EP1898909A1 Quinoline derivatives as antibacterial agents |
| 03/19/2008 | EP1898900A2 Antimicrobial compositions comprising esters of hydroxycarboxylic acids |
| 03/19/2008 | EP1898893A1 Antimicrobial and antiinflammatory composition |
| 03/19/2008 | EP1711174B1 Adjuvant compositions |
| 03/19/2008 | EP1691813B1 Ready-for-use injectable solution of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one, sterile, stable; closed system for packing the solution, process for eliminating alkaline residuals of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one crystals; |
| 03/19/2008 | EP1581535B9 Pyrrolopyridazine derivatives |
| 03/19/2008 | EP1562933B1 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders |
| 03/19/2008 | EP1530573B1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 03/19/2008 | EP1511751B1 Pyrazolo[1,5-a]pyrimidine compounds as antiviral agents |
| 03/19/2008 | EP1362031B1 Pharmaceutically active piperidine derivatives |
| 03/19/2008 | EP1283711B1 Peptide deformylase inhibitors |
| 03/19/2008 | EP1246628A4 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| 03/19/2008 | EP1042293B1 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 03/19/2008 | EP0920527B1 SYNTHESIS OF beta-LACTAM ANTIBACTERIALS USING SOLUBLE SIDE CHAIN ESTERS AND ENZYME ACYLASE |
| 03/19/2008 | CN101146825A A molecule and chimeric molecules thereof |
| 03/19/2008 | CN101146823A Molecules and chimeric molecules thereof |
| 03/19/2008 | CN101146811A Hiv整合酶抑制剂 Hiv integrase inhibitors |
| 03/19/2008 | CN101146793A Novel heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity |
| 03/19/2008 | CN101146789A Chemical compounds |
| 03/19/2008 | CN101146551A Adjuvant composition comprising aluminium phosphate and 3D-MPL |
| 03/19/2008 | CN101146540A Hiv整合酶抑制剂 Hiv integrase inhibitors |
| 03/19/2008 | CN101143892A 丙型肝炎三肽抑制剂 Tripeptide inhibitor of hepatitis C |
| 03/19/2008 | CN101143872A 3-halogen substituted cephalosporin derivative |
| 03/19/2008 | CN101143871A 头孢菌素衍生物 Cephalosporin derivatives |
| 03/19/2008 | CN101143870A Novel cephalosporin derivative |
| 03/19/2008 | CN101143861A B ring 4'-single substituted flavone compounds, preparation method and use |
| 03/19/2008 | CN101143859A Novel compound, its synthesis method and therapeutical uses |
| 03/19/2008 | CN101143853A Biphenyltetrazoles compounds and preparation method thereof |
| 03/19/2008 | CN101143221A Central airway administration for systemic delivery of therapeutics |
| 03/19/2008 | CN101143216A Escherichia coli TolC antibody targeting effect improving drug-resistant bacteria sensitivity to antibiotic technology |
| 03/19/2008 | CN101143198A Medicine for treating malignant lymph node tuberculosis |
| 03/19/2008 | CN101143195A Traditional Chinese medicine for treating pulmonary tuberculosis and sequela |
| 03/19/2008 | CN101143173A Capsule for treating acute dysentery and acute diarrhea and its preparation method |
| 03/19/2008 | CN101143157A Tyrosol and tyrosol bypass salidroside plant extraction and preparation and use thereof |
| 03/19/2008 | CN101143153A Lactobacillus signal molecule microecological preparation and preparation method thereof |
| 03/19/2008 | CN101143146A Cefoperazone sodium and sulbactam sodium composition |
| 03/19/2008 | CN101143133A Sodium fusidate freezing-dried powder injection |
| 03/19/2008 | CN100375786C Recombinant MVA capable of expressing structural HCV antigens |
| 03/19/2008 | CN100375742C 4-oxoquinoline compounds and its use |
| 03/19/2008 | CN100375614C Dripping pills with jaundice eliminating liver protecting functions and its preparation method |
| 03/19/2008 | CN100375613C Schizandrol dripping pills for decreasing aminopherase and method for preparing the same |
| 03/18/2008 | US7345171 Isethionate salt of a selective CKD4 inhibitor |
| 03/18/2008 | US7345151 Antagonists specific for denatured collagen and methods of using same |
| 03/18/2008 | US7345066 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 03/18/2008 | US7345062 Substituted acylhydroxamic acids and method of reducing TNFαlevels |
| 03/18/2008 | US7345050 Imidazo(1,2a)pyridine or pyrazolo(2,3a)pyridine derivatives; Alzheimer's and Parkinson's Disease; nervous system, brain, and psychological disorders |
| 03/18/2008 | US7345048 Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitors |
| 03/18/2008 | US7345025 Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells |
| 03/18/2008 | US7345024 Pharmaceutical preparation, method for its production as well as its use |
| 03/18/2008 | US7344869 Isolated DNA comprising one or more genes specific for 5S clavam biosynthesis, vectors comprising such DNA and Streptomyces hosts capable of improved clavulanic acid production |
| 03/18/2008 | US7344724 proteins and genes codes, used for medical diagnosis, screening biological targets and as vaccines against gramnegative bacterial infections |
| 03/18/2008 | US7344719 Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof |
| 03/18/2008 | US7344709 Administering interferon-beta (IFN- beta 9), after failed treatment with interferon- alpha |
| 03/18/2008 | CA2388050C Antibiotic caprazamycins and process for producing the same |
| 03/18/2008 | CA2355239C Pharmaceutical formulations |
| 03/18/2008 | CA2329128C Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 03/18/2008 | CA2219659C Rapamycin derivatives |
| 03/18/2008 | CA2166102C Redirection of cellular immunity by receptor chimeras |
| 03/18/2008 | CA2154982C Preparation of .alpha.1 antichymotrypsin |
| 03/13/2008 | WO2008031105A1 Polymeric guanidine salt-based germicides |
| 03/13/2008 | WO2008031090A1 Compositions for the treatment of hoof diseases |
| 03/13/2008 | WO2008031087A1 Compositions comprising a c2-c14 carboxylic acid and a surfactant for treating hoof diseases |
| 03/13/2008 | WO2008030512A2 Polystyrene sulfonate polymer tablets, their preparation and use |
| 03/13/2008 | WO2008030511A2 Substituted 3,4,6,7-tetrahydro-5h, 1,2a,4a,8-tetraazacyclopenta[cd]phenalenes |
| 03/13/2008 | WO2008030119A1 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 03/13/2008 | WO2008029908A1 Stable lyophilized pharmaceutical preparation comprising antibody |
| 03/13/2008 | WO2008029882A1 2-alkyl-6-(pyrazolopyridin-4-yl)pyridazinone derivative, addition salt thereof, and pde inhibitor comprising the derivative or the salt as active ingredient |
| 03/13/2008 | WO2008029619A1 Ena antisense oligonucleotide having sequence-specific action |
| 03/13/2008 | WO2008028347A1 Combined antibiotics preparation |
| 03/13/2008 | WO2007146547A3 Piperazine enamines as antiviral agents |